**Surgery Partners Inc. Rejects Bain Capital's Acquisition Proposal, Confident in Growth Strategy**

Surgery Partners Inc. (SGRY), a prominent operator of short-stay surgical facilities, announced on June 17, 2025, that its Board's Special Committee has turned down Bain Capital's offer to acquire the remaining shares of the company. This decision highlights the Board's belief in Surgery Partners' potential for long-term growth as an independent entity.

The company reaffirmed its financial guidance for 2025, projecting revenues between $3.30 billion and $3.45 billion, with Adjusted EBITDA expected to range from $555 million to $565 million. Surgery Partners also plans to host an Investor Day in the latter half of 2025 to discuss its growth strategies and industry outlook.

The Board's rejection of Bain Capital's proposal reflects a strong confidence in Surgery Partners' ability to thrive independently. The company has a solid track record of earnings growth and consistent operational execution, which further supports its optimistic outlook.

However, the decision to remain independent may also indicate missed opportunities for immediate shareholder value realization. Analysts note that the rejection could be viewed as a potential loss for shareholders, depending on the premium Bain Capital offered. Additionally, Surgery Partners faces risks from regulatory changes, competition, and supply chain challenges, as well as uncertainties related to the economic impacts of pandemics and natural disasters.

From a financial analyst's perspective, the choice to stay independent suggests a strong belief in the company's intrinsic value and growth potential. The reaffirmation of financial guidance indicates confidence in meeting revenue and EBITDA targets. Analysts will closely monitor Surgery Partners' ability to sustain its growth trajectory amid industry challenges.

Market research analysts view the rejection of Bain Capital's acquisition proposal as a strategic move, emphasizing Surgery Partners' focus on leveraging its position in the outpatient surgical care market. The upcoming Investor Day will be crucial for stakeholders to gain insights into the company's future direction and competitive positioning. Key areas to watch include the company's emphasis on mergers and acquisitions (M&A) and operational efficiencies, particularly in a competitive healthcare landscape.

In summary, Surgery Partners Inc. is committed to its long-term growth strategy as an independent company, rejecting Bain Capital's acquisition proposal. The company remains optimistic about its financial projections for 2025 and plans to engage with investors to outline its future strategies. However, it must navigate various risks and challenges in the healthcare sector to maintain its growth momentum.